SS is characterized by a specific t(X;18) (p11.2; q11.2) chromosomal translocation that generates the SYT‐SSX (also known as SS18‐SSX) fusion, an oncogene that can be detected in more than 95% of cases of SS.2 Here, SS18 is linked to synovial sarcoma.